Carregant...
Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective
BACKGROUND: The EORTC has launched a phase II trial to assess safety and efficacy of SBRT for centrally located NSCLC: The EORTC 22113-08113—Lungtech trial. Due to neighbouring critical structures, these tumours remain challenging to treat. To guarantee accordance to protocol and treatment safety, a...
Guardat en:
| Publicat a: | Radiat Oncol |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4721147/ https://ncbi.nlm.nih.gov/pubmed/26791788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-015-0567-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|